S100A9 and breast carcinoma: To validate previous findings that S100A9 promotes breast cancer progression, we first knocked down S100A9 in MDA0MB-231 cells using two independent siRNAs targeting S100A9 (siS100A9 #1 and #2) (Supplementary Fig. S2A).